Influence of apolipoprotein E polymorphisms on serum creatinine levels and predicted glomerular filtration rate in healthy subjects

被引:21
作者
Liberopoulos, EN [1 ]
Miltiadous, GA
Cariolou, M
Kalaitzidis, R
Siamopoulos, KC
Elisaf, MS
机构
[1] Univ Ioannina, Sch Med, Dept Internal Med, GR-45110 Ioannina, Greece
[2] Cyprus Inst Neurol & Genet, DNA Identificat Lab, Mol Genet Dept B, Nicosia, Cyprus
关键词
apolipoprotein E; creatinine; GFR; lipids; lipoproteins; renal function;
D O I
10.1093/ndt/gfh349
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. There are conflicting results regarding the effect of apolipoprotein (ApoE) polymorphisms on the progression of a variety of renal diseases. However, there are no data on the possible effect of the ApoE alleles on serum creatinine levels and predicted glomerular filtration rate (GFR) in healthy subjects. Methods. 290 apparently healthy individuals were studied. ApoE genotyping was performed by the polymerase chain reaction; the Modification of Diet in Renal Disease equation (MDRD) predicted the GFR. Results. ApoE2 was associated with lower levels of total cholesterol, low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol, as well as with higher levels of triglycerides in our population. Furthermore, the ApoE2 allele was associated with increased serum creatinine levels compared with both the E3 and E4 alleles (1.04 +/- 0.13 vs 0.92 +/- 0.13 vs 0.88 +/- 0.11 mg/dl, respectively, P = 0.0077), while the MDRD-predicted GFR was decreased in ApoE2 carriers compared with both E3 and E4 carriers (80.3 +/- 10.2 vs 88.1 +/- 9.6 vs 89.3 +/- 9.7 ml/min/1.73 m(2), respectively, P = 0.031). These observations remained significant statistically even if the effect of ApoE polymorphisms on age- and body-mass index-adjusted serum creatinine and MDRD-predicted GFR was separately analysed in both men and women. Although, ApoE4 carriers tended to exhibit lower levels of serum creatinine and higher values of predicted GFR compared with the E3 carries, these differences did not reach statistical significance. Conclusions. ApoE2 allele seems to be associated with increased serum creatinine levels and decreased MDRD-predicted GFR in healthy subjects.
引用
收藏
页码:2006 / 2012
页数:7
相关论文
共 20 条
[1]   APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes -: Results of case-control and family-based studies [J].
Araki, S ;
Moczulski, DK ;
Hanna, L ;
Scott, LJ ;
Warram, JH ;
Krolewski, AS .
DIABETES, 2000, 49 (12) :2190-2195
[2]   Apolipoprotein E alleles, dyslipemia and kidney transplantation [J].
Bayés, B ;
Pastor, MC ;
Lauzurica, R ;
Riutort, N ;
Bonal, J ;
Bonet, J ;
Romero, R .
TRANSPLANTATION PROCEEDINGS, 2002, 34 (01) :373-+
[3]   ApoE polymorphism and albuminuria in diabetes mellitus: a role for LDL in the development of nephropathy in NIDDM? [J].
Boize, R ;
Benhamou, PY ;
Corticelli, P ;
Valenti, K ;
Bosson, JL ;
Halimi, S .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (01) :72-75
[4]   A protective role for kidney apolipoprotein E - Regulation of mesangial cell proliferation and matrix expansion [J].
Chen, GP ;
Paka, L ;
Kako, Y ;
Singhal, P ;
Duan, WL ;
Pillarisetti, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (52) :49142-49147
[5]   Preliminary report on the association of apolipoprotein E polymorphisms, with postoperative peak serum creatinine concentrations in cardiac surgical patients [J].
Chew, STH ;
Newman, MF ;
White, WD ;
Conlon, PJ ;
Saunders, AM ;
Strittmatter, WJ ;
Landolfo, K ;
Grocott, HP ;
Stafford-Smith, M .
ANESTHESIOLOGY, 2000, 93 (02) :325-331
[6]  
Eto M, 1995, CLIN GENET, V48, P288
[7]   Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients [J].
Eto, M ;
Saito, M ;
Okada, M ;
Kume, Y ;
Kawasaki, F ;
Matsuda, M ;
Yoneda, M ;
Matsuki, M ;
Takigami, S ;
Kaku, K .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (02) :243-251
[8]   Association between apolipoprotein E polymorphism and macroalbuminuria in patients with non-insulin dependent diabetes mellitus [J].
Ha, SK ;
Park, HS ;
Kim, KW ;
Kim, SJ ;
Kim, DH ;
Kim, JH ;
Lee, HY ;
Han, DS .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (09) :2144-2149
[9]   Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM [J].
Kimura, H ;
Suzuki, Y ;
Gejyo, F ;
Karasawa, R ;
Miyazaki, R ;
Suzuki, S ;
Arakawa, M .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (04) :666-673
[10]   Apolipoprotein E gone polymorphism, hypercholesterolemia and glomerular filtration rate in type 2 diabetic subjects:: A 9-year follow-up study [J].
Lehtinen, S ;
Rantalaiho, V ;
Wirta, O ;
Pasternack, A ;
Laippala, P ;
Koivula, T ;
Lehtimäki, T .
JOURNAL OF BIOMEDICAL SCIENCE, 2003, 10 (02) :260-265